| pubmed-article:16151834 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0079189 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0015259 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0392747 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0443172 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0522510 | lld:lifeskim |
| pubmed-article:16151834 | lifeskim:mentions | umls-concept:C0410158 | lld:lifeskim |
| pubmed-article:16151834 | pubmed:issue | 5-6 | lld:pubmed |
| pubmed-article:16151834 | pubmed:dateCreated | 2005-12-5 | lld:pubmed |
| pubmed-article:16151834 | pubmed:abstractText | The purpose of this study was to compare the effects of exercise intensity and exercise-induced muscle damage on changes in anti-inflammatory cytokines and other inflammatory mediators. Nine well-trained male runners completed three different exercise trials on separate occasions: (1) level treadmill running at 60% VO2max (moderate-intensity trial) for 60 min; (2) level treadmill running at 85% VO2max (high-intensity trial) for 60 min; (3) downhill treadmill running (-10% gradient) at 60% VO2max (downhill running trial) for 45 min. Blood was sampled before, immediately after and 1 h after exercise. Plasma was analyzed for interleukin-1 receptor antagonist (IL-1ra), IL-4, IL-5, IL-10, IL-12p40, IL-13, monocyte chemotactic protein-1 (MCP-1), prostaglandin E(2), leukotriene B(4) and heat shock protein 70 (HSP70). The plasma concentrations of IL-1ra, IL-12p40, MCP-1 and HSP70 increased significantly (P<0.05) after all three trials. Plasma prostaglandin E(2) concentration increased significantly after the downhill running and high-intensity trials, while plasma IL-10 concentration increased significantly only after the high-intensity trial. IL-4 and leukotriene B(4) did not increase significantly after exercise. Plasma IL-1ra and IL-10 concentrations were significantly higher (P<0.05) after the high-intensity trial than after both the moderate-intensity and downhill running trials. Therefore, following exercise up to 1 h duration, exercise intensity appears to have a greater effect on anti-inflammatory cytokine production than exercise-induced muscle damage. | lld:pubmed |
| pubmed-article:16151834 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16151834 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16151834 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16151834 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:16151834 | pubmed:issn | 1439-6319 | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:NosakaKazunor... | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:SuzukiKatsuhi... | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:CoombesJeff... | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:PeakeJonathan... | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:WilsonGaryG | lld:pubmed |
| pubmed-article:16151834 | pubmed:author | pubmed-author:HordernMatthe... | lld:pubmed |
| pubmed-article:16151834 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16151834 | pubmed:volume | 95 | lld:pubmed |
| pubmed-article:16151834 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16151834 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16151834 | pubmed:pagination | 514-21 | lld:pubmed |
| pubmed-article:16151834 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:meshHeading | pubmed-meshheading:16151834... | lld:pubmed |
| pubmed-article:16151834 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16151834 | pubmed:articleTitle | Plasma cytokine changes in relation to exercise intensity and muscle damage. | lld:pubmed |
| pubmed-article:16151834 | pubmed:affiliation | School of Human Sciences, and Consolidated Research Institute for Advanced Science and Medical Care, Waseda University, 2-579-15 Mikajima, Tokorozawa, Saitama, 359-1192, Japan. iac04127@kurenai.waseda.jp | lld:pubmed |
| pubmed-article:16151834 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16151834 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16151834 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16151834 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16151834 | lld:pubmed |
